Latest News

Upcoming Events

DuoBody news archive

Oct 2015

Genmab Achieves $3 Million Milestone for Progress in DuoBody Platform Collaboration with Janssen

Genmab Reaches $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen

May 2015

Genmab Enters Commercial DuoBody® Technology Agreement with BioNTech in Field of Immuno-oncology

February 2015

Genmab Enters Commercial DuoBody Technology Agreement with BioNovion in the Field of Immuno-Oncology 

December 2014

Genmab to Receive $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen

September 2014

Nature Protocols publishes DuoBody technology paper

July 2014

Genmab to Receive Milestone Payment in DuoBody Platform Collaboration with Janssen 

June 2014

Genmab Announces DuoBody and HexaBody Platform Collaboration with Undisclosed Biotechnology Company

Presentation on bispecific IgG1-Her2xCD3 at the Empowered Antibody Congress 2014 

May 2014

Presentation on bispecific IgG1-Her2xCD3 at PEGS 2014

March 2014

Presentation on IgG4 biology and the DuoBody platform at ATT 2014

January 2014

Genmab Announces DuoBody Platform Collaboration with Lilly

Presentation on the DuoBody platform at Peptalk 2014

December 2013

Genmab to Receive Milestone Payment in DuoBody Platform Collaboration with Janssen — Financial Guidance Improved

Genmab Announces Expansion of DuoBody Platform Collaboration with Janssen Biotech, Inc

November 2013

Dr Parren and Dr Schuurman headed roundtable discussions

DuoBody data presented at three conferences

Genmab at partnering conference

September 2013

Janssen presented DuoBody manufacturability data at the 4th Bispecific Antibody Summit 2013

Novel DuoBody data, focusing on CD3-bispecifics, presented at the 4th Bispecific Antibody Summit 2013

August 2013

Genmab Reaches Milestone in DuoBody Platform Collaboration with Janssen

June 2013

DuoBody was presented at the 30th conference on monoclonal antibodies and cancer stem cells 

April 2013

DuoBody was presented at PEGS, 2-3 May 2013

December 2012

Genmab Reaches Milestone in DuoBody Platform Collaboration with Janssen

July 2012

Genmab Enters Broad Collaboration with Janssen Biotech, Inc. for DuoBody Platform

June 2012

Genmab Enters DuoBody Technology Collaboration With Novartis

December 2011

Genmab Announces Progress with DuoBody® Platform